Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
HR 2666 - MVP Act HR 7384 - Creating Hope Reauthorization Act of 2024 Safe Labor Draft Legislation
HR 2666 - MVP Act HR 7384 - Creating Hope Reauthorization Act of 2024 Safe Labor Draft Legislation
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BLUEBIRD BIO, INC. via BLUEBIRD BIO, INC.
2024 · second_quarter · 2T
HR 2666 - MVP Act HR 7384 - Creating Hope Reauthorization Act of 2024 Safe Labor Draft Legislation
Medicaid Program: Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program (CMS-2434-P)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
Source: Senate LDA
HR 2666 - MVP Act HR 7384 - Creating Hope Reauthorization Act of 2024 Safe Labor Draft Legislation
Creating Hope Reauthorization Act of 2024
Client: BLUEBIRD BIO, INC. · Firm: BLUEBIRD BIO, INC.
HR 2666 - MVP Act HR 7384 - Creating Hope Reauthorization Act of 2024 Safe Labor Draft Legislation
Creating Hope Reauthorization Act of 2024
Client: BLUEBIRD BIO, INC. · Firm: BLUEBIRD BIO, INC.
HR 2666 - MVP Act HR 7384 - Creating Hope Reauthorization Act of 2024 Safe Labor Draft Legislation
Creating Hope Reauthorization Act of 2024
Client: BLUEBIRD BIO, INC. · Firm: BLUEBIRD BIO, INC.
HR 2666 - MVP Act HR 7384 - Creating Hope Reauthorization Act of 2024 Safe Labor Draft Legislation
HR 2666 - MVP Act Medicaid Program: Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program (CMS-2434-P)
HR 2666 - MVP Act
HR 2666 - MVP Act Medicaid Program: Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program (CMS-2434-P) CMMI sought bluebird input on potential gene therapy demo for sickle cell disease beneficiaries of Medicaid
HR 2666 - MVP Act
HR 2666 - MVP Act Medicaid Program: Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program (CMS-2434-P)
HR 2666 - MVP Act Medicaid Program: Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program (CMS-2434-P) CMMI sought bluebird input on potential gene therapy demo for sickle cell disease beneficiaries of Medicaid
HR 2666 - MVP Act Medicaid Program: Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program (CMS-2434-P) CMMI sought bluebird input on potential gene therapy demo for sickle cell disease beneficiaries of Medicaid
BLUEBIRD BIO, INC. via BLUEBIRD BIO, INC.
2024 · second_quarter · Q2
HR 2666 - MVP Act HR 7384 - Creating Hope Reauthorization Act of 2024 Safe Labor Draft Legislation
Medicaid Program: Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program (CMS-2434-P)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
BLUEBIRD BIO, INC. via BLUEBIRD BIO, INC.
2024 · first_quarter · Q1
HR 2666 - MVP Act HR 7384 - Creating Hope Reauthorization Act of 2024 Safe Labor Draft Legislation
Medicaid Program: Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program (CMS-2434-P)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
BLUEBIRD BIO, INC. via BLUEBIRD BIO, INC.
2023 · fourth_quarter · 4A
HR 2666 - MVP Act Medicaid Program: Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program (CMS-2434-P) CMMI sought bluebird input on potential gene therapy demo for sickle cell disease beneficiaries of Medicaid
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BLUEBIRD BIO, INC. via BLUEBIRD BIO, INC.
2023 · fourth_quarter · 4A
HR 2666 - MVP Act Medicaid Program: Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program (CMS-2434-P) CMMI sought bluebird input on potential gene therapy demo for sickle cell disease beneficiaries of Medicaid
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BLUEBIRD BIO, INC. via BLUEBIRD BIO, INC.
2023 · fourth_quarter · Q4
HR 2666 - MVP Act Medicaid Program: Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program (CMS-2434-P) CMMI sought bluebird input on potential gene therapy demo for sickle cell disease beneficiaries of Medicaid
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BLUEBIRD BIO, INC. via BLUEBIRD BIO, INC.
2023 · third_quarter · 3A
HR 2666 - MVP Act Medicaid Program: Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program (CMS-2434-P)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BLUEBIRD BIO, INC. via BLUEBIRD BIO, INC.
2023 · second_quarter · 2A
HR 2666 - MVP Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUEBIRD BIO, INC. via BLUEBIRD BIO, INC.
2023 · third_quarter · Q3
HR 2666 - MVP Act Medicaid Program: Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program (CMS-2434-P)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BLUEBIRD BIO, INC. via BLUEBIRD BIO, INC.
2023 · second_quarter · Q2
HR 2666 - MVP Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUEBIRD BIO, INC. via BLUEBIRD BIO, INC.
2023 · first_quarter · RA
Matters affecting medical/health issues.